S&P Futures
3,273.00-29.25(-0.89%)Dow Futures
26,316.00-241.00(-0.91%)Nasdaq Futures
11,206.00-136.75(-1.21%)
Axonics Modulation Technologies, Inc. (AXNX)
Chart Events
Performance Outlook
| Previous Close | 48.89 |
| Open | 48.60 |
| Bid | 0.00 x 1000 |
| Ask | 50.23 x 800 |
| Day's Range | 46.92 - 49.07 |
| 52 Week Range | 15.25 - 52.10 |
| Volume | 152,348 |
| Avg. Volume | 527,826 |
| Market Cap | 1.931B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.56 |
| Earnings Date | Nov 04, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 55.56 |
Fair Value
Related Research
- Business Wire
Axonics® Submits PMA Supplement to FDA to Further Expand MRI Labeling
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, has submitted a premarket approval (PMA) supplement to the FDA for the purpose of gaining detachable extremity coil magnetic resonance imaging (MRI) conditional labeling for 1.5T and 3.0T MR scanners.
- Zacks
Axonics Modulation Technologies (AXNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Axonics (AXNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Investor's Business Daily
Dow Jones Sheds Early Gains Into The Close But Remains Positive; Microsoft, Apple Form New Buy Points
The Dow Jones rose in today's market but pared earlier gains to a much smaller gain by the close. The Tuesday coronavirus stimulus deadline draws closer.
